BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21810058)

  • 41. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnosis of mycotic infections in patients with tuberculosis of the respiratory organs].
    Solov'eva TN; Karaev ZO; Ignat'eva SM; Mizonov VN
    Probl Tuberk; 1991; (7):37-40. PubMed ID: 1754587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Invasive mould disease in haematological patients].
    Ruiz-Camps I; Jarque I
    Rev Iberoam Micol; 2014; 31(4):249-54. PubMed ID: 25434346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous infections due to opportunistic molds: uncommon presentations.
    Vennewald I; Wollina U
    Clin Dermatol; 2005; 23(6):565-71. PubMed ID: 16325064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA analysis in the study of fungal infections in the immunocompromised host.
    Zervos MJ; Vazquez JA
    Clin Lab Med; 1996 Mar; 16(1):73-88. PubMed ID: 8867584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspergillus and other fungi.
    Robinson LA
    Chest Surg Clin N Am; 1999 Feb; 9(1):193-225, x. PubMed ID: 10079987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
    Kim K; Lee MH; Kim J; Lee KS; Kim SM; Jung MP; Han J; Sung KW; Kim WS; Jung CW; Yoon SS; Im YH; Kang WK; Park K; Park CH
    Am J Hematol; 2002 Oct; 71(2):75-9. PubMed ID: 12353303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspergillus infections in the critically ill.
    Dutkiewicz R; Hage CA
    Proc Am Thorac Soc; 2010 May; 7(3):204-9. PubMed ID: 20463249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fungal infections--diagnosis, pathogens and therapy].
    Willinger B
    Wien Med Wochenschr; 2007; 157(19-20):530-2. PubMed ID: 18030560
    [No Abstract]   [Full Text] [Related]  

  • 52. Invasive candidiasis in immunocompromised hospitalized patients.
    Sims CR; Ostrosky-Zeichner L; Rex JH
    Arch Med Res; 2005; 36(6):660-71. PubMed ID: 16216647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fungal brain infections.
    Scully EP; Baden LR; Katz JT
    Curr Opin Neurol; 2008 Jun; 21(3):347-52. PubMed ID: 18451721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactomannan testing might be useful for early diagnosis of fusariosis.
    Mikulska M; Furfaro E; Del Bono V; Gualandi F; Raiola AM; Molinari MP; Gritti P; Sanguinetti M; Posteraro B; Bacigalupo A; Viscoli C
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):367-9. PubMed ID: 22280997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y; Chen SP; Shu YG; Xu YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
    Camps IR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
    Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.